NASDAQ:KLRS

A stock that deserves closer examination: Kalaris Therapeutics Inc (KLRS)
Arcelia Reed
Within its last year performance, KLRS rose by 7.87%, with highs and lows ranging from $12.90 to $2.14, whereas the ...

Within its last year performance, KLRS rose by 7.87%, with highs and lows ranging from $12.90 to $2.14, whereas the ...